2 completed. 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Completed 2 |
Follow Aviptadil Placebo: new trials by email Literature Review of Aviptadil Placebo trials Research Report on Aviptadil Placebo
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Aviptadil for Severely Ill Inpatients With COVID-19 (An ACTIV-3b/TESICO Treatment Trial) Aviptadil, Aviptadil Placebo, Corticosteroid - Covid19 | Phase 3 | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | 471 | 2021-04-20 | 2025-10-09 |
| ACTIV-3b: Therapeutics for Severely Ill Inpatients With COVID-19 Remdesivir, Remdesivir Placebo, Aviptadil - Covid19 | Phase 3 | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | 473 | 2021-04-20 | 2025-10-24 |
COVID-19 (2) · Coronaviridae Infections (2) · Coronavirus Infections (2) · Nidovirales Infections (2) · RNA Virus Infections (2) · Severe Acute Respiratory Syndrome (2) · Virus Diseases (2)
National Institute of Allergy and Infectious Diseases (NIAID) (2)
United States (2)
Prof. James Neaton (2) · Samuel Brown, MD (2)